Invitrogen™ Human PILR-alpha ELISA Kit

Ref.: BL-RE-106303Manufacturer ref.: EH368RBX10 10 x 96 tests
€4,995.00 excl. VAT

Human PILR-alpha quantitates human PILR-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PILR-alpha.

Accession number
AV021745; FDF03 cell surface receiver; FDF03; PILR-alpha inhibitor receptor; alpha type 2 receptor related to paired immunoglobulin; alpha type 2 receptor related to paired immunoglobulin; alpha type 2 receptor related to paired immunoglobulin; Pilra
Dose range
5.5 to 1.500 pg/ml
Sensitivity of the dosage
5.5 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human PILR-alpha quantitates human PILR-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PILR-alpha.

Human PILR-alpha quantitates human PILR-alpha in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human PILR-alpha.

Dephosphorylation of SHP-1 mediated protein tyrosine residues is essential for the regulation of several cellular signaling pathways. The superfamily of inhibitory receptors has two types of limbs: tyrosine-based immunoreceptor-inhibitor receptors (TIM) and their non-ITIM-enactant counterparts. Control of cellular signaling via SHP-1 is thought to occur by balancing PILR alpha mediated inhibition with PILR beta mediated activation. This particular gene encodes the ITIM member of the receptor pair, which works in the inhibitory role. Cell signaling pathways are based on dynamic interaction between activation and inhibition processes. Dephosphorylation of SHP-1 mediated protein tyrosine residues is essential for the regulation of several cellular signaling pathways. The superfamily of inhibitory receptors has two types of limbs: tyrosine-based immunoreceptor-inhibitor receptors (TIM) and their non-ITIM-enactant counterparts. Control of cellular signaling via SHP-1 is thought to occur by balancing PILR alpha mediated inhibition with PILR beta mediated activation. These receptor genes similar to paired immunoglobulins are located in a tandem one-to-one orientation on chromosome 7. This particular gene encodes the ITIM member of the receptor pair, which plays the inhibitory role.

Sensitivity

Sensitivity of the dosage: 5.5 pg/ml.

Measurement range

Dose range: 5.5 to 1.500 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: PILRA.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17874130
Specifications
Accession numberAV021745; FDF03 cell surface receiver; FDF03; PILR-alpha inhibitor receptor; alpha type 2 receptor related to paired immunoglobulin; alpha type 2 receptor related to paired immunoglobulin; alpha type 2 receptor related to paired immunoglobulin; Pilra
Dose range5.5 to 1.500 pg/ml
Sensitivity of the dosage5.5 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9UKJ1
Gene symbol(s)PILRA
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusUse exclusively for research
TargetPILRA
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 μl; Serum, 50 μl; Plasma, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH368RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.